🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

BRIEF-Health Canada Says Intend To Suspend Allergan's Biocell Breast Implants Licences As A Precautionary Measure

Published 2019-04-04, 01:54 p/m
© Reuters.  BRIEF-Health Canada Says Intend To Suspend Allergan's Biocell Breast Implants Licences As A Precautionary Measure

April 4 (Reuters) - Health Canada:

* INFORMATION UPDATE - HEALTH CANADA ADVISES ALLERGAN OF ITS INTENT TO SUSPEND ITS LICENCES FOR BIOCELL BREAST IMPLANTS AS A PRECAUTIONARY MEASURE

* HEALTH CANADA - AS OF APRIL 4, BEEN NOTIFIED OF 28 CONFIRMED CANADIAN CASES OF BIA-ALCL, OF WHICH 24 (86%) INVOLVE ALLERGAN'S BIOCELL BREAST IMPLANT

* HEALTH CANADA - REVIEWING INFORMATION ON SAFETY OF TEXTURED BREAST IMPLANTS, INCLUDES ANY NEW EVIDENCE PROVIDED BY ALLERGAN IN NEXT 15 CALENDAR DAYS

* HEALTH CANADA - ENGAGING INTERNATIONALLY ON SAFETY OF BREAST IMPLANTS, INCLUDING RECENT MEETINGS WITH FRENCH REGULATOR AND FDA

* HEALTH CANADA - IF SATISFACTORY RESPONSE IS NOT RECEIVED FROM ALLERGAN IN NEXT 15 CALENDAR DAYS, INTENTION TO SUSPEND BIOCELL MEDICAL DEVICE LICENCES

* HEALTH CANADA - IN CONTACT WITH FRANCE ABOUT ITS DECISION TODAY TO SUSPEND SALE OF MACRO-TEXTURED BREAST IMPLANTS, POLYURETHANE-COATED BREAST IMPLANTS

* HEALTH CANADA - ENTIRETY OF ITS SAFETY REVIEW OF BREAST IMPLANTS AND BIA-ALCL WILL BE AVAILABLE BY END OF APRIL

* HEALTH CANADA SAYS STARTED A SECOND SAFETY REVIEW ON SYSTEMIC SYMPTOMS ASSOCIATED WITH BREAST IMPLANTS

* HEALTH CANADA - RESULTS OF THE SECOND SAFETY REVIEW WILL BE MADE PUBLIC IN SUMMER 2019.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.